P Poredos

Summary

Affiliation: University Medical Centre
Country: Slovenia

Publications

  1. doi Is aspirin still the drug of choice for management of patients with peripheral arterial disease?
    Pavel Poredos
    Department of Vascular Disease, University Medical Centre Ljubljana, Slovenia
    Vasa 42:88-95. 2013
  2. ncbi Testing endothelial function and its clinical relevance
    Pavel Poredos
    Department of Vascular Disease, University Medical Centre, Ljubljana, Slovenia
    J Atheroscler Thromb 20:1-8. 2013
  3. doi Enlargement of the diameter of the peripheral arteries in patients with idiopathic venous thrombosis
    P Poredos
    Department of Vascular Disease, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia
    Ultraschall Med 33:E268-74. 2012
  4. pmc Intensive insulin treatment improves forearm blood flow in critically ill patients: a randomized parallel design clinical trial
    Ivan Zuran
    Department of Angiology, Endocrinology and Rheumatology, General Hospital Celje, 3000 Celje, Slovenia
    Crit Care 13:R198. 2009
  5. ncbi Antiplatelet and antithrombotic treatment of patients with peripheral arterial disease
    P Poredos
    University Medical Centre, Department for Vascular Diseases, Ljubljana, Slovenia
    Int Angiol 29:20-6. 2010
  6. ncbi Does the preventive effect of different drugs depend on location of the atherosclerotic process?
    P Poredos
    Department of Vascular Diseases, University Medical Center Ljubljana, Slovenia
    Int Angiol 27:274-80. 2008
  7. ncbi The role of inflammation in venous thromboembolism and the link between arterial and venous thrombosis
    P Poredos
    Department for Vascular Disease, University Medical Centre, Ljubljana, Slovenia
    Int Angiol 26:306-11. 2007
  8. doi In patients with idiopathic venous thrombosis, interleukin-10 is decreased and related to endothelial dysfunction
    Pavel Poredos
    Department of Vascular Disease, University Medical Centre Ljubljana, Zaloska 7, 1000, Ljubljana, Slovenia
    Heart Vessels 26:596-602. 2011
  9. ncbi Effect of metabolic abnormalities on endothelial dysfunction in normotensive offspring of subject with hypertension
    B Zizek
    Department of Vascular Diseases, University Medical Centre Ljubljana, Ljubljana, Slovenia
    Int Angiol 32:386-93. 2013
  10. ncbi Endothelial dysfunction predictor of structural changes of arterial wall in type I diabetes
    P Poredos
    Department for Vascular Diseases, University Clinical Center, Ljubljana, Slovenia
    Int Angiol 25:280-6. 2006

Collaborators

Detail Information

Publications29

  1. doi Is aspirin still the drug of choice for management of patients with peripheral arterial disease?
    Pavel Poredos
    Department of Vascular Disease, University Medical Centre Ljubljana, Slovenia
    Vasa 42:88-95. 2013
    ..Further, new studies on PAD patients are necessary to better define the role of anti-platelet agents in these patients and one of the promising ways of access to anti-platelet treatment would be personalized anti-platelet therapy...
  2. ncbi Testing endothelial function and its clinical relevance
    Pavel Poredos
    Department of Vascular Disease, University Medical Centre, Ljubljana, Slovenia
    J Atheroscler Thromb 20:1-8. 2013
    ....
  3. doi Enlargement of the diameter of the peripheral arteries in patients with idiopathic venous thrombosis
    P Poredos
    Department of Vascular Disease, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia
    Ultraschall Med 33:E268-74. 2012
    ..As the data indicate a relationship between atherosclerosis and venous thrombosis (VT), we investigated whether the diameter of the peripheral arteries is larger in patients with idiopathic VT than in healthy subjects...
  4. pmc Intensive insulin treatment improves forearm blood flow in critically ill patients: a randomized parallel design clinical trial
    Ivan Zuran
    Department of Angiology, Endocrinology and Rheumatology, General Hospital Celje, 3000 Celje, Slovenia
    Crit Care 13:R198. 2009
    ..The purpose of the study was to test the hypothesis that intensive insulin treatment may influence forearm blood flow independently of global hemodynamic indicators...
  5. ncbi Antiplatelet and antithrombotic treatment of patients with peripheral arterial disease
    P Poredos
    University Medical Centre, Department for Vascular Diseases, Ljubljana, Slovenia
    Int Angiol 29:20-6. 2010
    ..However the combination is related to an increased risk of bleeding. Moderate intensity of warfarin treatment would be acceptable in the presence of coexisting indications such as atrial fibrillation or recent venous thrombosis...
  6. ncbi Does the preventive effect of different drugs depend on location of the atherosclerotic process?
    P Poredos
    Department of Vascular Diseases, University Medical Center Ljubljana, Slovenia
    Int Angiol 27:274-80. 2008
    ....
  7. ncbi The role of inflammation in venous thromboembolism and the link between arterial and venous thrombosis
    P Poredos
    Department for Vascular Disease, University Medical Centre, Ljubljana, Slovenia
    Int Angiol 26:306-11. 2007
    ..A relation was also found between preclinical and clinical atherosclerotic disease and VTE. Also in line with these arguments are the preventive effects of aspirin and statins in both arterial and venous disease...
  8. doi In patients with idiopathic venous thrombosis, interleukin-10 is decreased and related to endothelial dysfunction
    Pavel Poredos
    Department of Vascular Disease, University Medical Centre Ljubljana, Zaloska 7, 1000, Ljubljana, Slovenia
    Heart Vessels 26:596-602. 2011
    ..This inflammatory response could be the consequence of the disease, but most probably is involved in the pathogenesis of venous thrombosis...
  9. ncbi Effect of metabolic abnormalities on endothelial dysfunction in normotensive offspring of subject with hypertension
    B Zizek
    Department of Vascular Diseases, University Medical Centre Ljubljana, Ljubljana, Slovenia
    Int Angiol 32:386-93. 2013
    ....
  10. ncbi Endothelial dysfunction predictor of structural changes of arterial wall in type I diabetes
    P Poredos
    Department for Vascular Diseases, University Clinical Center, Ljubljana, Slovenia
    Int Angiol 25:280-6. 2006
    ....
  11. ncbi Idiopathic venous thrombosis is related to systemic inflammatory response and to increased levels of circulating markers of endothelial dysfunction
    M K Jezovnik
    Department of Vascular Disease, University Medical Centre Ljubljana, Slovenia
    Int Angiol 29:226-31. 2010
    ..The aim of the present study was to investigate the inflammatory markers and their relationship to idiopathic venous thrombosis...
  12. ncbi Factors influencing the recanalisation rate of deep venous thrombosis
    M K Jezovnik
    Department of Vascular Disease, Ljubljana University Medical Centre, Zaloska 7, Ljubljana, Slovenia
    Int Angiol 31:169-75. 2012
    ..Therefore, the aim of our study was to investigate whether levels of the circulating inflammatory markers and other factors like fibrinolytic parameters, sex, and extent of the thrombotic occlusion are related to the recanalisation rate...
  13. ncbi Endothelial dysfunction in Buerger's disease and its relation to markers of inflammation
    M Joras
    Department for Vascular Medicine, University Medical Centre, Ljubljana, Slovenia
    Eur J Clin Invest 36:376-82. 2006
    ....
  14. ncbi Prevention of ischemic events in patients with peripheral arterial disease design, baseline characteristics and 2-year results an observational study
    A Blinc
    Department of Vascular Diseases, University of Ljubljana Medical Centre, Ljubljana, Slovenia
    Int Angiol 30:555-66. 2011
    ..We followed the survival of PAD patients and tested whether PAD remains an adverse prognostic indicator in spite of treatment according to the current European guidelines on cardiovascular disease prevention...
  15. ncbi Pharmacological prevention of atherothrombotic events in patients with peripheral arterial disease
    A Blinc
    Department of Vascular Diseases, University of Ljubljana Medical Centre, Ljubljana, Slovenia
    Eur J Clin Invest 37:157-64. 2007
    ..In conclusion, pharmacological secondary prevention of cardiovascular morbidity and mortality in patients with PAD should be as comprehensive as that in patients with established coronary or cerebrovascular disease...
  16. ncbi Interrelationship between peripheral arterial occlusive disease, carotid atherosclerosis and flow mediated dilation of the brachial artery
    P Poredos
    Department of Vascular Disease, University Medical Centre, Ljubljana, Slovenia
    Int Angiol 22:83-7. 2003
    ....
  17. ncbi Insulin resistance adds to endothelial dysfunction in hypertensive patients and in normotensive offspring of subjects with essential hypertension
    B Zizek
    Department of Angiology, University Medical Centre, Ljubljana, Slovenia
    J Intern Med 249:189-97. 2001
    ....
  18. ncbi Endothelium-dependent and independent dilation capability of peripheral arteries in patients with systemic lupus erythematosus and antiphospholipid syndrome
    M Stalc
    Department of Vascular Diseases, University Medical Centre Ljubljana, Slovenia
    Clin Exp Rheumatol 29:616-23. 2011
    ..The study evaluated the systemic inflammatory response and endothelium-dependent and independent function of the brachial artery (BA) in systemic lupus erythematosus (SLE) patients with and without antiphospholipid syndrome (APS)...
  19. ncbi Relation of blunted dilation of the brachial artery in insulin-dependent diabetes mellitus to microalbuminuria
    P Poredos
    Department of Vascular Disease, University Medical Centre, Ljubljana, Slovenia
    Am J Cardiol 86:364-7. 2000
    ..The diabetic state does not significantly influence the vascular smooth muscle functional capability...
  20. ncbi Endothelial dysfunction in the pathogenesis of atherosclerosis
    P Poredos
    Department of Vascular Disease, University Medical Centre, Ljubljana, Slovenia
    Clin Appl Thromb Hemost 7:276-80. 2001
    ..Using these tests it is possible to follow the dose response of harmful effects of risk factors, and the effects of preventive procedures on vessel wall function...
  21. ncbi Dependence of morphological changes of the carotid arteries on essential hypertension and accompanying risk factors
    B Zizek
    Department of Angiology, University Medical Centre, Ljubljana, Slovenia
    Int Angiol 21:70-7. 2002
    ....
  22. ncbi Therapeutic equivalence of the generic and the reference atorvastatin in patients with increased coronary risk
    M Boh
    Medical Research and Pharmacovigilance, KRKA d d Novo mesto, Ljubljana, Slovenia
    Int Angiol 30:366-74. 2011
    ..In patients with increased low density lipoprotein cholesterol (LDL-C) levels of cholesterol and changes of total coronary risk were followed...
  23. doi The influence of atorvastatin on walking performance in peripheral arterial disease
    U Bregar
    Department of Vascular Disease, University of Ljubljana Medical Centre, Ljubljana, Slovenia
    Vasa 38:155-9. 2009
    ..We examined whether statins used in moderate dosages with the aim of reaching the target levels for hypercholesterolemia could improve walking performance in patients with peripheral arterial disease...
  24. ncbi The usefulness of transcutaneous oximetry in assessing the success of percutaneous transluminal angioplasty
    M Stalc
    Department of Vascular Disease, Clinical Centre, Ljubljana, Slovenija
    Eur J Vasc Endovasc Surg 24:528-32. 2002
    ..to identify whether monitoring transcutaneous oxygen pressure (TcpO(2)) can provide an objective method of assessing the results of PTA...
  25. ncbi Endothelial dysfunction in post-myocardial infarction patients with various expressions of risk factors
    B Erzen
    Department of Vascular Diseases, University Medical Centre, Ljubljana, Slovenia
    Endothelium 14:185-91. 2007
    ..It appears that ED may occur and precede development of atherosclerosis in the absence of classic risk factors. These novel findings can have important clinical implications...
  26. ncbi Endothelial dysfunction and cardiovascular disease
    P Poredos
    University Medical Centre Ljubljana, Department of Vascular Disease, Slovenia
    Pathophysiol Haemost Thromb 32:274-7. 2002
    ..Using these non-invasive tests it is possible to follow the dose-response of harmful effects or risk factors, and the effects of preventive procedures on vessel wall function...
  27. ncbi Determination of amputation level in ischaemic limbs using tcPO2 measurement
    P Poredos
    University Medical Centre, Department of Vascular Diseases, Ljubljana, Slovenia
    Vasa 34:108-12. 2005
    ..Therefore we aimed to rank the probability of primary wound healing at the most distal level and to answer the question if there is a lower limit of tcPO2 below which healing cannot occur...
  28. ncbi Endothelial dysfunction in the pathogenesis of atherosclerosis
    P Poredos
    Department of Vascular Disease, University Medical Centre, Ljubljana, Slovenia
    Int Angiol 21:109-16. 2002
    ..Using these tests it is possible to follow the dose-response of harmful effects or risk factors, and the effects of preventive procedures on vessel wall function...
  29. ncbi The metabolic syndrome: definition, diagnosis and management
    S Novo
    Int Angiol 27:220-31. 2008